Company intelligence / Profile preview

Accelerated Enrollment Solutions

Horsham, Pennsylvania, United Statesglobalaes.com ↗

Ownership: Private
Employees: ~707
Development stage: Other

Overview

AES specializes in accelerating patient enrollment and site activation for global clinical trials. It leverages proprietary patient databases (~100 million households), standardized site infrastructure (>160 sites globally), and predictive analytics to deliver faster recruitment—often twice the industry average—and greater certainty for sponsors. During COVID‑19, it launched programs to transfer patients between sites to maintain trial continuity.

Therapeutic areas: OtherInfectious Diseases
Modalities: All modalitiesSmall moleculeBiologicVaccine
Industry: Contract Research Organization

Partnerships

Biopharma sponsors globally

Beyond the preview

Go deeper on Accelerated Enrollment Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Accelerated Enrollment Solutions.

Explore the full profile